India committee recommends emergency use authorisation for Merck's COVID-19 pill – report

BENGALURU (Reuters) – An expert committee of India’s drug regulator recommended emergency use authorisation (EUA) for Merck’s COVID-19 pill molnupiravir, and Serum Institute of India’s Covovax and Biological E’s corbevax vaccines, the Economic Times reported. Read full story

Source : https://www.thestar.com.my/news/world/2021/12/28/india-committee-recommends-emergency-use-authorisation-for-merck039s-covid-19-pill—report